Macrolide Drugs Market by Drug Type and Distribution Channel - Global Industry Analysis and Forecast To 2023

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Macrolide Drugs Market, By Drug Type

4.1.       Introduction

4.2.       Macrolide Drugs Market Assessment and Forecast, By Drug Type, 2017-2023

4.3.       Erythromycin

4.3.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

4.4.       Clarithromycin

4.4.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

4.5.       Roxithromycin

4.5.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

4.6.       Troleandomycin

4.6.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

4.7.       Fidaxomicin

4.7.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

4.8.       Azithromycin

4.8.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

4.9.       Dirithromycin

4.9.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

4.10.    Telithromycin

4.10.1.      Market Assessment and Forecast, By Region, 2017-2023 ($Million)

5.       Macrolide Drugs Market, By Distribution Channel

5.1.       Introduction

5.2.       The Macrolide Drugs Market Assessment and Forecast, By Distribution Channel, 2017-2023

5.3.       Hospital pharmacies

5.3.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

5.4.       Clinics

5.4.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

5.5.       Hospitals

5.5.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

5.6.       Retail pharmacies

5.6.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

5.7.       Online pharmacies

5.7.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

6.       Macrolide Drugs Market, By Region

6.1.       Introduction

6.2.       Macrolide Drugs Market Assessment and Forecast, By Region, 2017-2023 ($Million)

6.3.       North America

6.3.1.  Market Assessment and Forecast, By Country, 2017-2023 ($Million)

6.3.2.  Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.3.3.  Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.3.4.  U.S.

6.3.4.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.3.4.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.3.5.  Canada

6.3.5.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.3.5.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.3.6.  Mexico

6.3.6.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.3.6.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.4.       Europe

6.4.1.  Market Assessment and Forecast, By Country, 2017-2023 ($Million)

6.4.2.  Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.4.3.  Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.4.4.  Germany

6.4.4.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.4.4.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.4.5.  France

6.4.5.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.4.5.2.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.4.6.  UK

6.4.6.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.4.6.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.4.7.  Italy

6.4.7.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.4.7.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.4.8.  Spain

6.4.8.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.4.8.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.4.9.  Rest of Europe

6.4.9.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.4.9.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.5.       Asia-Pacific

6.5.1.  Market Assessment and Forecast, By Country, 2017-2023 ($Million)

6.5.2.  Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.5.3.  Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.5.4.  Japan

6.5.4.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.5.4.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.5.5.  China

6.5.5.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.5.5.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.5.6.  Australia

6.5.6.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.5.6.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.5.7.  India

6.5.7.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.5.7.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.5.8.  South Korea

6.5.8.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.5.8.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.5.9.  Rest of Asia-Pacific

6.5.9.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.5.9.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.6.       Rest of the World

6.6.1.  Market Assessment and Forecast, By Country, 2017-2023 ($Million)

6.6.2.  Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.6.3.  Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.6.4.  Brazil

6.6.4.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.6.4.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.6.5.  Turkey

6.6.5.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.6.5.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.6.6.  Saudi Arabia

6.6.6.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.6.6.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.6.7.  South Africa

6.6.7.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.6.7.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.6.8.  United Arab Emirates

6.6.8.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.6.8.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

6.6.9.  Others

6.6.9.1.    Market Assessment and Forecast, By Drug Type, 2017-2023 ($Million)

6.6.9.2.    Market Assessment and Forecast, By Distribution Channel, 2017-2023 ($Million)

7.       Company Profiles

7.1.       Eli Lilly & Co.

7.1.1.  Business Overview

7.1.2.  Product Portfolio

7.1.3.  Key Financials

7.1.4.  Strategic Developments

7.2.       Pfizer, Inc.

7.2.1.  Business Overview

7.2.2.  Product Portfolio

7.2.3.  Strategic Developments

7.3.       Sanofi

7.3.1.  Business Overview

7.3.2.  Product Portfolio

7.3.3.  Key Financials

7.3.4.  Strategic Developments

7.4.       Merck & Co., Inc.

7.4.1.  Business Overview

7.4.2.  Product Portfolio

7.4.3.  Strategic Developments

7.5.       Abbott Laboratories

7.5.1.  Business Overview

7.5.2.  Product Portfolio

7.5.3.  Key Financials

7.5.4.  Strategic Developments

7.6.       Akorn, Inc.

7.6.1.  Business Overview

7.6.2.  Product Portfolio

7.6.3.  Strategic Developments

7.7.       Sandoz International GmbH

7.7.1.  Business Overview

7.7.2.  Product Portfolio

7.7.3.  Strategic Developments

7.8.       WOCKHARDT

7.8.1.  Business Overview

7.8.2.  Product Portfolio

7.8.3.  Key Financials

7.8.4.  Strategic Developments

---

List of Tables

Table 1.Global Macrolide Drugs Market, By Drug Type ($Million), 2017-2023

Table 2.Erythromycin Market, By Region ($Million), 2017-2023

Table 3.Clarithromycin Market, By Region ($Million), 2017-2023

Table 4.Roxithromycin Market, By Region ($Million), 2017-2023

Table 5.Troleandomycin Market, By Region ($Million), 2017-2023

Table 6.Fidaxomicin Market, By Region ($Million), 2017-2023

Table 7.Azithromycin Market, By Region ($Million), 2017-2023

Table 8.Dirithromycin Market, By Region ($Million), 2017-2023

Table 9.Telithromycin Market, By Region ($Million), 2017-2023

Table 10.Global Macrolide Drugs Market, By Distribution Channel ($Million), 2017-2023

Table 11.Hospital pharmacies Market, By Region ($Million), 2017-2023

Table 12.Clinics Market, By Region ($Million), 2017-2023

Table 13.Hospitals Market, By Region ($Million), 2017-2023

Table 14.Retail pharmacies Market, By Region ($Million), 2017-2023

Table 15.Online pharmacies Market, By Region ($Million), 2017-2023

Table 16.North America Macrolide Drugs Market, By Country, 2017-2023 ($Million)

Table 17.North America Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 18.North America Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 19.U.S. Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 20.U.S. Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 21.Canada Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 22.Canada Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 23.Mexico Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 24.Mexico Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 25.Europe Macrolide Drugs Market, By Country, 2017-2023 ($Million)

Table 26.Europe Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 27.Europe Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 28.Germany Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 29.Germany Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 30.France Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 27.France Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 28.UK Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 29.UK Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 30.Italy Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 31.Italy Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 32.Spain Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 33.Spain Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 34.Rest of Europe Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 35.Rest of Europe Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 36.Asia-Pacific Macrolide Drugs Market, By Country, 2017-2023 ($Million)

Table 37.Asia-Pacific Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 38.Asia-Pacific Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 39.Japan Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 40.Japan Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 41.China Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 42.China Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 43.Australia Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 44.Australia Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 45.India Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 46.India Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 47.South Korea Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 48.South Korea Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 49.Rest of Asia-Pacific Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 50.Rest of Asia-Pacific Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 51.Rest of the World Macrolide Drugs Market, By Country, 2017-2023 ($Million)

Table 52.Rest of the World Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 53.Rest of the World Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 54.Brazil Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 55.Brazil Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 56.Turkey Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 57.Turkey Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 58.Saudi Arabia Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 59.Saudi Arabia Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 60.South Africa Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 61.South Africa Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 62.United Arab Emirates Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 63.United Arab Emirates Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 64.Others Macrolide Drugs Market, By Drug Type, 2017-2023 ($Million)

Table 65.Others Macrolide Drugs Market, By Distribution Channel, 2017-2023 ($Million)

Table 66.Eli Lilly & Co.: Key Strategic Developments, 2017-2017

Table 67.Pfizer, Inc.: Key Strategic Developments, 2017-2017

Table 68.Sanofi: Key Strategic Developments, 2017-2017

Table 69.Merck & Co., Inc.: Key Strategic Developments, 2017-2017

Table 70.Abbott Laboratories: Key Strategic Developments, 2017-2017

Table 71.Akorn, Inc.: Key Strategic Developments, 2017-2017

Table 72.Sandoz International GmbH: Key Strategic Developments, 2017-2017

Table 73.WOCKHARDT: Key Strategic Developments, 2017-2017

---

List of Figures

Figure 1.Global Macrolide Drugs Market Share, By Drug Type, 2017 & 2023
Figure 2.Macrolide Drugs Market, By Distribution Channel, 2017, ($Million)
Figure 3.Macrolide Drugs Market, By Region, 2017, ($Million)
Figure 4.Merck & Co., Inc.: Net Revenues, 2017-2017 ($Million)
Figure 5.Merck & Co., Inc.: Net Revenue Share, By Segment, 2017
Figure 6.Merck & Co., Inc.: Net Revenue Share, By Geography, 2017
Figure 7.Abbott Laboratories: Net Revenues, 2017-2017 ($Million)
Figure 8.Abbott Laboratories: Net Revenue Share, By Segment, 2017
Figure 9.Abbott Laboratories: Net Revenue Share, By Geography, 2017

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

• Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

• Number of patients for particular device or medical procedure and
• Repeated use of particular device depending on health and condition of patient

• Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country